|
1
|
Kluiver J, Kroesen BJ, Poppema S and van
den Berg A: The role of microRNAs in normal hematopoiesis and
hematopoietic malignancies. Leukemia. 20:1931–1936. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nowak D, Stewart D and Koeffler HP:
Differentiation therapy of leukemia: 3 decades of development.
Blood. 113:3655–3665. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schaar D, Goodell L, Aisner J, et al: A
phase I clinical trial of 12- O-tetradecanoylphorbol-13-acetate for
patients with relapsed/refractory malignancies. Cancer Chemother
Pharmacol. 57:789–795. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chang SH and Hla T: Gene regulation by RNA
binding proteins and microRNAs in angiogenesis. Trends Mol Med.
17:650–658. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim VN, Han J and Siomi MC: Biogenesis of
small RNAs in animals. Nat Rev Mol Cell Biol. 10:126–139. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Davis-Dusenbery BN and Hata A: Mechanisms
of control of microRNA biogenesis. J Biochem. 148:381–392.
2010.
|
|
7
|
Kasashima K, Nakamura Y and Kozu T:
Altered expression profiles of microRNAs during TPA-induced
differentiation of HL-60 cells. Biochem Biophys Res Commun.
322:403–410. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lal A, Pan Y, Navarro F, et al:
miR-24-mediated downregulation of H2AX suppresses DNA repair in
terminally differentiated blood cells. Nat Struct Mol Biol.
16:492–498. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Forrest AR, Kanamori-Katayama M, Tomaru Y,
et al: Induction of microRNAs, mir-155, mir-222, mir-424 and
mir-503, promotes monocytic differentiation through combinatorial
regulation. Leukemia. 24:460–466. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang XS and Zhang JW: The microRNAs
involved in human myeloid differentiation and
myelogenous/myeloblastic leukemia. J Cell Mol Med. 12:1445–1455.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Matsumoto E, Hatanaka M, Bohgaki M and
Maeda S: PKC pathway and ERK/MAPK pathway are required for
induction of cyclin D1 and p21Waf1 during 12-o-tetradecanoylphorbol
13-acetate-induced differentiation of myeloleukemia cells. Kobe J
Med Sci. 52:181–194. 2006.PubMed/NCBI
|
|
12
|
Schaar DG, Liu H, Sharma S, et al:
12-O-tetradecanoylphorbol-13-acetate (TPA)-induced dual-specificity
phosphatase expression and AML cell survival. Leuk Res.
29:1171–1179. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang J, Xiang G, Mitchelson K and Zhou Y:
Microarray profiling of monocytic differentiation reveals
miRNA-mRNA intrinsic correlation. J Cell Biochem. 112:2443–2453.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim S, Lee HS, Lee SK, et al:
12-O-Tetradecanoyl phorbol-13-acetate (TPA)-induced growth arrest
is increased by silibinin by the downregulation of cyclin B1 and
cdc2 and the upregulation of p21 expression in MDA-MB231 human
breast cancer cells. Phytomedicine. 17:1127–1132. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Park MH, Park SY and Kim Y: Induction of
proline-rich tyrosine kinase2 (Pyk2) through C/EBPbeta is involved
in PMA-induced monocyte differentiation. FEBS Lett. 582:415–422.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guo Y, Chen Z, Zhang L, et al: Distinctive
microRNA profiles relating to patient survival in esophageal
squamous cell carcinoma. Cancer Res. 68:26–33. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tusher VG, Tibshirani R and Chu G:
Significance analysis of microarrays applied to the ionizing
radiation response. Proc Natl Acad Sci USA. 98:5116–5121. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen C, Ridzon DA, Broomer AJ, et al:
Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic
Acids Res. 33:e1792005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li X, Liu J, Zhou R, Huang S and Chen XM:
Gene silencing of MIR22 in acute lymphoblastic leukaemia involves
histone modifications independent of promoter DNA methylation. Br J
Haematol. 148:69–79. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Heller G, Schmidt WM, Ziegler B, et al:
Genome-wide transcriptional response to 5-aza-2′-deoxycytidine and
trichostatin a in multiple myeloma cells. Cancer Res. 68:44–54.
2008.
|
|
21
|
Cameron JE, Fewell C, Yin Q, et al:
Epstein-Barr virus growth/latency III program alters cellular
microRNA expression. Virology. 382:257–266. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nagpal JK, Rani R, Trink B and Saini KS:
Targeting miRNAs for drug discovery: a new paradigm. Curr Mol Med.
10:503–510. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ichimura A, Ruike Y, Terasawa K and
Tsujimoto G: miRNAs and regulation of cell signaling. FEBS J.
278:1610–1618. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tsuchiya N, Izumiya M, Ogata-Kawata H, et
al: Tumor suppressor miR-22 determines p53-dependent cellular fate
through post-transcriptional regulation of p21. Cancer Res.
71:4628–4639. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang S, He X, Ding J, et al: Upregulation
of miR-23a approximately 27a approximately 24 decreases
transforming growth factor-beta-induced tumor-suppressive
activities in human hepatocellular carcinoma cells. Int J Cancer.
123:972–978. 2008. View Article : Google Scholar
|
|
26
|
Wang P, Zou F, Zhang X, et al: microRNA-21
negatively regulates Cdc25A and cell cycle progression in colon
cancer cells. Cancer Res. 69:8157–8165. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sayed D, Rane S, Lypowy J, et al:
MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths. Mol
Biol Cell. 19:3272–3282. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zaidi SK, Dowdy CR, van Wijnen AJ, et al:
Altered Runx1 subnuclear targeting enhances myeloid cell
proliferation and blocks differentiation by activating a
miR-24/MKP-7/MAPK network. Cancer Res. 69:8249–8255. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lin RJ, Lin YC, Chen J, et al: microRNA
signature and expression of Dicer and Drosha can predict prognosis
and delineate risk groups in neuroblastoma. Cancer Res.
70:7841–7850. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Vaksman O, Hetland TE, Trope CG, Reich R
and Davidson B: Argonaute, Dicer, and Drosha are upregulated along
tumor progression in serous ovarian carcinoma. Hum Pathol. May
29–2012.(Epub ahead of print).
|
|
31
|
Yan M, Huang HY, Wang T, et al:
Dysregulated expression of dicer and drosha in breast cancer.
Pathol Oncol Res. 18:343–348. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Frezzetti D, De Menna M, Zoppoli P, et al:
Upregulation of miR-21 by Ras in vivo and its role in tumor growth.
Oncogene. 30:275–286. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Takagi S, Nakajima M, Kida K, Yamaura Y,
Fukami T and Yokoi T: MicroRNAs regulate human hepatocyte nuclear
factor 4alpha, modulating the expression of metabolic enzymes and
cell cycle. J Biol Chem. 285:4415–4422. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Schmeier S, MacPherson CR, Essack M, et
al: Deciphering the transcriptional circuitry of microRNA genes
expressed during human monocytic differentiation. BMC Genomics.
10:5952009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhou R, Hu G, Gong AY and Chen XM: Binding
of NF-kappaB p65 subunit to the promoter elements is involved in
LPS-induced transactivation of miRNA genes in human biliary
epithelial cells. Nucleic Acids Res. 38:3222–3232. 2010. View Article : Google Scholar : PubMed/NCBI
|
